Skip to main content
. 2018 Feb 13;3(2):157–166. doi: 10.1016/j.bioactmat.2018.01.006

Fig. 5.

Fig. 5

A. GS doped PLA and PMMA filaments. (A) 2.5 wt% gentamicin PLA filament; (B) Control PLA filament; (C) control PMMA filament; (D) 2.5 wt% gentamicin PMMA filament. B. A–C) 1 wt% gentamicin PLA filament D) 1 wt% gentamicin PMMA filament.